Cross-cultural adaptation and validation of simplified Chinese version of the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ) 2.0 with its assessment in clinical setting.

[1]  A. Gasbarrini,et al.  Adaptation and Validation of the Spine Oncology Study Group Outcomes Questionnaire in Italian Language , 2022, Global spine journal.

[2]  A. Mesfin,et al.  Patient Reported Outcomes in Metastatic Spine Disease: Concurrent Validity of PROMIS with the Spine Oncology Study Group Outcome Questionnaire , 2022, Spine.

[3]  K. Schaser,et al.  eCross-cultural adaptation of the spine oncology-specific SOSGOQ2.0 questionnaire to German language and the assessment of its validity and reliability in the clinical setting , 2021, BMC Cancer.

[4]  H. Shang,et al.  Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L , 2021, Health and Quality of Life Outcomes.

[5]  Panya Luksanapruksa,et al.  Validity and reliability of the Thai version of the Spine Oncology Study Group Outcomes Questionnaire version 2.0 to assess Quality of Life in Patients with Spinal Metastasis. , 2021, The spine journal : official journal of the North American Spine Society.

[6]  Chih-Kai Hong,et al.  The Chinese version of the American shoulder and elbow surgeons standardized shoulder assessment form questionnaire, patient self-report section: a cross-cultural adaptation and validation study , 2021, BMC Musculoskeletal Disorders.

[7]  C. R. Goodwin,et al.  Spinal Metastases 2021: A Review of the Current State of the Art and Future Directions. , 2021, The spine journal : official journal of the North American Spine Society.

[8]  M. Ferrone,et al.  Prospective comparison of the accuracy of the New England Spinal Metastasis Score (NESMS) to legacy scoring systems in prognosticating outcomes following treatment of spinal metastases. , 2021, The spine journal : official journal of the North American Spine Society.

[9]  Y. Yamada,et al.  Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience. , 2020, Neurosurgery.

[10]  Shunping Li,et al.  Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores , 2020, The Patient - Patient-Centered Outcomes Research.

[11]  Zhengwang Sun,et al.  An Independent Inter-observer Reliability and Intra-observer Reproducibility Evaluation of SINS Scoring and Kostuik Classification Systems for Spinal Tumor. , 2020, World neurosurgery.

[12]  M. O. Papuga,et al.  An Evaluation of PROMIS in Patients With Primary or Metastatic Spine Tumors , 2019, Spine.

[13]  C. Bettegowda,et al.  Psychometric evaluation and adaptation of the Spine Oncology Study Group Outcomes Questionnaire to evaluate health‐related quality of life in patients with spinal metastases , 2018, Cancer.

[14]  T. Teunis,et al.  Validation of the Spine Oncology Study Group-Outcomes Questionnaire to assess quality of life in patients with metastatic spine disease. , 2017, The spine journal : official journal of the North American Spine Society.

[15]  M. Ferrone,et al.  Most efficient questionnaires to measure quality of life, physical function, and pain in patients with metastatic spine disease: a cross-sectional prospective survey study. , 2017, The spine journal : official journal of the North American Spine Society.

[16]  P. Belmont,et al.  Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS). , 2016, The spine journal : official journal of the North American Spine Society.

[17]  C. Bünger,et al.  Healthcare costs attributable to the treatment of patients with spinal metastases: a cohort study with up to 8 years follow-up , 2015, BMC Cancer.

[18]  Ximing Xu,et al.  Validation of the Simplified Chinese Version of the Functional Rating Index for Patients With Nonspecific Neck Pain in Mainland China , 2015, Spine.

[19]  E. Tai,et al.  Normative Data for the Singapore English and Chinese SF-36 Version 2 Health Survey. , 2014, Annals of the Academy of Medicine, Singapore.

[20]  M. Fehlings,et al.  Assessment of quality of life after surgery for spinal metastases: position statement of the Global Spine Tumour Study Group. , 2013, World neurosurgery.

[21]  S. Berven,et al.  Introducing a New Health-Related Quality of Life Outcome Tool for Metastatic Disease of the Spine: Content Validation Using the International Classification of Functioning, Disability, and Health; On Behalf of the Spine Oncology Study Group , 2010, Spine.

[22]  A. Falicov,et al.  Impact of Surgical Intervention on Quality of Life in Patients With Spinal Metastases , 2006, Spine.

[23]  C. Bombardier,et al.  Guidelines for the process of cross-cultural adaptation of self-report measures. , 2000, Spine.

[24]  C. Bombardier,et al.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. , 1993, Journal of clinical epidemiology.

[25]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.